Stocktoria
Microbot Medical Inc. MBOT
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 1992-03-25
Microbot Medical Inc. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| R&D expense | $6.3M | $6.6M | $5.7M | $7.7M | $6.2M |
| SG&A expense | $8.5M | $5.0M | — | — | — |
| Operating income | -$14.7M | -$11.6M | -$9.9M | -$13.3M | -$11.4M |
| Net income | -$13.1M | -$11.4M | -$10.7M | -$13.2M | -$11.3M |
| EPS (diluted) | $-0.29 | $-0.73 | $-1.05 | $-1.81 | — |
| Operating cash flow | -$13.0M | -$8.8M | -$8.5M | -$11.5M | -$9.4M |
| Free cash flow | -$13.1M | -$8.9M | -$8.6M | -$11.6M | -$9.4M |
| Cash & equivalents | $3.9M | $3.1M | $2.5M | $2.4M | $13.5M |
| Inventory | $584,000 | — | — | — | — |
| Total assets | $81.5M | $6.0M | $8.3M | $9.5M | $16.8M |
| Total liabilities | $4.0M | $2.5M | $3.8M | $2.2M | $2.4M |
| Shareholders' equity | $77.6M | $3.5M | $4.5M | $7.3M | $14.4M |
Source: SEC EDGAR filings · CIK 0000883975 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.